Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
07/03/201815:30GlobeNewswire Inc.CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational UpdateNASDAQ:CTMXCytomX Therapeutics Inc
07/03/201815:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTMXCytomX Therapeutics Inc
05/03/201816:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
01/03/201815:05GlobeNewswire Inc.CytomX to Present at Upcoming Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
22/02/201815:05GlobeNewswire Inc.CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference CallNASDAQ:CTMXCytomX Therapeutics Inc
14/02/201813:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
12/02/201817:01Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CTMXCytomX Therapeutics Inc
01/02/201808:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
29/01/201816:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
18/12/201707:00GlobeNewswire Inc.CytomX Therapeutics Added to NASDAQ Biotechnology IndexNASDAQ:CTMXCytomX Therapeutics Inc
28/11/201707:30GlobeNewswire Inc.CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody TherapeuticNASDAQ:CTMXCytomX Therapeutics Inc
15/11/201710:51Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CTMXCytomX Therapeutics Inc
07/11/201715:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
01/11/201715:05GlobeNewswire Inc.CytomX to Present at the Jefferies 2017 London Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
26/10/201715:26GlobeNewswire Inc.CytomX Therapeutics to Announce Third Quarter 2017 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
24/10/201715:05GlobeNewswire Inc.CytomX Therapeutics Appoints Charles S. Fuchs, M.D., MPH to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
24/10/201714:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
16/10/201712:00GlobeNewswire Inc.CytomX Announces Upcoming Poster Presentations at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conf...NASDAQ:CTMXCytomX Therapeutics Inc
03/10/201715:05PR Newswire (US)Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-OncologyNASDAQ:CTMXCytomX Therapeutics Inc
22/09/201714:01Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CTMXCytomX Therapeutics Inc
21/09/201707:00PR Newswire (US)UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive TeamNASDAQ:CTMXCytomX Therapeutics Inc
13/09/201715:05GlobeNewswire Inc.CytomX to Present at the Cantor Fitzgerald Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
08/09/201715:39GlobeNewswire Inc.CytomX Announces Upcoming Trials in Progress Poster Presentations at European Society for Medical Oncology Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
10/08/201715:05GlobeNewswire Inc.CytomX to Present at the 2017 Wedbush PacGrow Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
07/08/201715:05GlobeNewswire Inc.CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference CallNASDAQ:CTMXCytomX Therapeutics Inc
27/07/201707:00GlobeNewswire Inc.CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year UpdateNASDAQ:CTMXCytomX Therapeutics Inc
29/06/201707:00GlobeNewswire Inc.CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjuga...NASDAQ:CTMXCytomX Therapeutics Inc
28/06/201707:00GlobeNewswire Inc.CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 TrialNASDAQ:CTMXCytomX Therapeutics Inc
25/05/201707:00GlobeNewswire Inc.CytomX to Present at the Jefferies 2017 Global Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
17/05/201707:00GlobeNewswire Inc.CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual MeetingNASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

Su Consulta Reciente

Delayed Upgrade Clock